EIB approves EUR 8.1 billion for renewable energy, energy efficiency, sustainable transport, and agriculture
12 December 2019
Helping businesses to cut energy use in Italy, Belgium, France and the Czech Republic
Financing renewable energy in Germany, Brazil and Nepal
Protecting rural communities from extreme weather in Laos and Nigeria
The European Investment Bank (EIB) today approved EUR 8.1 billion of new financing for climate action, sustainable development, health, and education investment across Europe and around the world. This included support for large and small-scale renewable energy projects, for the development of electric vehicles, and for improving the energy efficiency of homes. EIB financing approved today will also help to build water infrastructure and rural roads in developing countries impacted by a changing climate.
The EIB Board of Directors also agreed to support research and development in partnership with the Bill and Melinda Gates Foundation and the EU Malaria Fund to better control malaria.
“The climate emergency demands that we act now. And the EIB is responding. As I confirmed at COP 25 in Madrid earlier this week the EU Bank is committed to doubling support for climate action around the world and mobilising EUR 1 trillion for climate investment over the next decade. Projects approved today demonstrate the EIB’s commitment to accelerate the take up of clean energy, sustainable transport, energy efficiency, water, and agricultural investment that reduces emissions and protects vulnerable communities against extreme weather. Most of these projects are highly innovative. Innovation will help us tackle global warming and give us a win-win: as we deal with climate change we will be reducing the innovation investment gap between Europe and its global competitors. There is no trade off: we can and must do both things,“ said European Investment Bank President Werner Hoyer.
Accelerating malaria research and vaccination programmes
In partnership with the EU Malaria Fund and the Bill and Melinda Gates Foundation, the EIB agreed to finance research and development to better control malaria and potentially eradicate the virus that impacts the lives of millions of people around the world.
The EIB also approved new support to scale up activity by GAVI, the Vaccine Alliance. This will strengthen immunisation programmes by UNICEF, the world’s biggest buyer and supplier of vaccines for developing countries.
Encouraging business to invest in climate action
Private sector engagement to cut energy use is key to reduce carbon emissions.
The EIB approved EUR 3.8 billion of new financing for business investment. This includes targeted support for climate action in partnership with local banks and financial partners in Belgium, Denmark, France, Slovakia and the Czech Republic.
The EIB also agreed to support corporate investment In Denmark, France and Germany to improve hearing aids, scale-up food ingredient research, and expand bioscience laboratories.
New financing for business investment provided in partnership with local banks in Belgium, France, Italy, Slovenia and Spain was also approved, along with new private sector financing in Georgia and Serbia.
Helping cities to cut energy use
Refurbishment of existing urban infrastructure to enable more efficient energy and water use, as well as better protect against extreme weather, is essential to accelerate climate action.
The EIB agreed new financing for smart grid and water infrastructure in Linz, Austria, backed sustainable urban transport investment in the Slovakian capital Bratislava and new investment to improve wastewater treatment in Mitrovica, Kosovo.
The EU Bank also approved new investment by municipal and regional authorities to improve the energy efficiency of housing across the Netherlands .
The EIB will also finance the construction of new drinking water treatment facilities and expansion of clean water distribution to benefit more than 2 million people in Niamey, the capital of Niger, a city challenged by frequent drought and migration from across the Sahel.
Accelerating clean and renewable energy investment
The EIB agreed new financing to support a new large-scale wind farm in the North Sea, small scale renewable and energy efficiency projects in Italy, and the expansion of electricity distribution in western Nepal to enable remote communities to benefit from hydropower.
New renewable energy projects including hydropower and wind farms across Brazil will also be supported by the EIB.
Ensuring sustainable transport alternatives to car use
Train travellers in Estonia and the Czech Republic will benefit from new rail investment, approved by the EIB today, that will modernise existing tracks and upgrade regional rail services.
Backing agricultural and bio-economy investment in countries affected by drought
The EIB Board agreed a new streamlined financing programme to accelerate agri-food investment across Spain and a new pan-European initiative intended to increase investment in the circular bio-economy.
Supporting sustainable development to protect vulnerable communities worldwide
Thousands of people living across Cambodia, Laos and Nigeria will benefit from new investment approved today to better protect rural roads from extreme weather. This investment will reduce travel and transport costs as well as the risk that farmers cannot access markets due to impassable roads
Expanding schools and transforming hospitals
The EIB agreed to support the construction of new schools in Vienna, backing for a new hospital in Kouvola and extension of an existing hospital in Kymenlaakso, both in Finland, and financing for a new university hospital in Malmo, Sweden.
Meeting at the EIB’s headquarters in Luxembourg, representatives of the EIB’s shareholders, the 28 EU member states, approved a total of 48 different loans, including 8 projects earmarked for financing by the EIB under the European Fund for Strategic Investments (EFSI), the financial pillar of the Juncker plan.
The EIB and AM-Pharma B.V. have signed a EUR 24m financing agreement to accelerate the development of the innovative Dutch clinical stage biopharmaceutical company’s recombinant alkaline phosphatase enzyme (recAP), used to treat acute kidney injury (AKI). The financing will support a multi-national ‘phase III trial’ of recAP in 1,400 patients with sepsis-associated-acute kidney injury (SA-AKI). It also allows the Company to fund the steps required to submit market authorization applications following the trial’s completion. The EIB’s financing is supported under the “Infectious Diseases Finance Facility” (IDFF) of the InnovFin programme under the EU’s research and innovation programme Horizon 2020.
Covestro has agreed a loan with the EIB for EUR 225 million. The loan will provide medium term funding to strengthen Covestro’s research and development (R&D) work in the areas of sustainability and circular economy within the European Union.
With €5.4 billion of overall financing 2019 was a strong year for the EIB Group in Poland. The Group’s activity was 13 % higher than in the previous year and in line with the trend of the past five years. Loans granted to public and private counterparts by the EIB amounted to €4.3 billion, while the European Investment Fund (EIF) provided €1.1 billion in guarantees and equity investments to small and medium-sized businesses and mid-caps.